Essential hypertension Clinical Trials
Conditions / Essential hypertension
Delta Trials catalogs 231 clinical trials for Essential hypertension in its publicly accessible dataset. Within this set, 13 currently recruiting participants and 163 trials have reached completion. This research occurs across 1,319 participating sites around the world. An additional 55 trials are in other active phases such as not yet recruiting or pending status. Since 2020, 4 trials were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.
Trial Status
231
Total Trials
13
Recruiting
163
Completed
55
Other Active
4
Terminated since 2020
1319
Study Locations
Browse by location (1319 total)
- Seoul, South Korea 53 trialsAll trials in Seoul, South Korea
- Beijing, China 18 trialsAll trials in Beijing, China
- Shanghai, China 13 trialsAll trials in Shanghai, China
- Chongqing, China 13 trialsAll trials in Chongqing, China
- Daegu, South Korea 11 trialsAll trials in Daegu, South Korea
- Incheon, South Korea 9 trialsAll trials in Incheon, South Korea
- Chengdu, China 9 trialsAll trials in Chengdu, China
- Houston, United States 9 trialsAll trials in Houston, United States
- Paris, France 8 trialsAll trials in Paris, France
- Guangzhou, China 8 trialsAll trials in Guangzhou, China
- Wŏnju, South Korea 8 trialsAll trials in Wŏnju, South Korea
- Paris, France 8 trialsAll trials in Paris, France
- Taipei, Taiwan 7 trialsAll trials in Taipei, Taiwan
- Busan, South Korea 7 trialsAll trials in Busan, South Korea
- Xi'an, China 7 trialsAll trials in Xi'an, China
- Xi’an, China 7 trialsAll trials in Xi’an, China
- Suwon, South Korea 7 trialsAll trials in Suwon, South Korea
- Xian, China 7 trialsAll trials in Xian, China
- Tianjin, China 7 trialsAll trials in Tianjin, China
- Hangzhou, China 7 trialsAll trials in Hangzhou, China